Michael Widrich

Thomas Adler, Johannes Brandstetter, Michael Widrich et al.

In order to quickly adapt to new data, few-shot learning aims at learning from few examples, often by using already acquired knowledge. The new data often differs from the previously seen data due to a domain shift, that is, a change of the input-target distribution. While several methods perform well on small domain shifts like new target classes with similar inputs, larger domain shifts are still challenging. Large domain shifts may result in high-level concepts that are not shared between the original and the new domain, whereas low-level concepts like edges in images might still be shared and useful. For cross-domain few-shot learning, we suggest representation fusion to unify different abstraction levels of a deep neural network into one representation. We propose Cross-domain Hebbian Ensemble Few-shot learning (CHEF), which achieves representation fusion by an ensemble of Hebbian learners acting on different layers of a deep neural network. Ablation studies show that representation fusion is a decisive factor to boost cross-domain few-shot learning. On the few-shot datasets miniImagenet and tieredImagenet with small domain shifts, CHEF is competitive with state-of-the-art methods. On cross-domain few-shot benchmark challenges with larger domain shifts, CHEF establishes novel state-of-the-art results in all categories. We further apply CHEF on a real-world cross-domain application in drug discovery. We consider a domain shift from bioactive molecules to environmental chemicals and drugs with twelve associated toxicity prediction tasks. On these tasks, that are highly relevant for computational drug discovery, CHEF significantly outperforms all its competitors. Github: https://github.com/ml-jku/chef

Michael Widrich, Bernhard Schäfl, Hubert Ramsauer et al.

A central mechanism in machine learning is to identify, store, and recognize patterns. How to learn, access, and retrieve such patterns is crucial in Hopfield networks and the more recent transformer architectures. We show that the attention mechanism of transformer architectures is actually the update rule of modern Hopfield networks that can store exponentially many patterns. We exploit this high storage capacity of modern Hopfield networks to solve a challenging multiple instance learning (MIL) problem in computational biology: immune repertoire classification. Accurate and interpretable machine learning methods solving this problem could pave the way towards new vaccines and therapies, which is currently a very relevant research topic intensified by the COVID-19 crisis. Immune repertoire classification based on the vast number of immunosequences of an individual is a MIL problem with an unprecedentedly massive number of instances, two orders of magnitude larger than currently considered problems, and with an extremely low witness rate. In this work, we present our novel method DeepRC that integrates transformer-like attention, or equivalently modern Hopfield networks, into deep learning architectures for massive MIL such as immune repertoire classification. We demonstrate that DeepRC outperforms all other methods with respect to predictive performance on large-scale experiments, including simulated and real-world virus infection data, and enables the extraction of sequence motifs that are connected to a given disease class. Source code and datasets: https://github.com/ml-jku/DeepRC

Hubert Ramsauer, Bernhard Schäfl, Johannes Lehner et al.

We introduce a modern Hopfield network with continuous states and a corresponding update rule. The new Hopfield network can store exponentially (with the dimension of the associative space) many patterns, retrieves the pattern with one update, and has exponentially small retrieval errors. It has three types of energy minima (fixed points of the update): (1) global fixed point averaging over all patterns, (2) metastable states averaging over a subset of patterns, and (3) fixed points which store a single pattern. The new update rule is equivalent to the attention mechanism used in transformers. This equivalence enables a characterization of the heads of transformer models. These heads perform in the first layers preferably global averaging and in higher layers partial averaging via metastable states. The new modern Hopfield network can be integrated into deep learning architectures as layers to allow the storage of and access to raw input data, intermediate results, or learned prototypes. These Hopfield layers enable new ways of deep learning, beyond fully-connected, convolutional, or recurrent networks, and provide pooling, memory, association, and attention mechanisms. We demonstrate the broad applicability of the Hopfield layers across various domains. Hopfield layers improved state-of-the-art on three out of four considered multiple instance learning problems as well as on immune repertoire classification with several hundreds of thousands of instances. On the UCI benchmark collections of small classification tasks, where deep learning methods typically struggle, Hopfield layers yielded a new state-of-the-art when compared to different machine learning methods. Finally, Hopfield layers achieved state-of-the-art on two drug design datasets. The implementation is available at: https://github.com/ml-jku/hopfield-layers

Markus Hofmarcher, Andreas Mayr, Elisabeth Rumetshofer et al.

Due to the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there is an urgent need for novel therapies and drugs. We conducted a large-scale virtual screening for small molecules that are potential CoV-2 inhibitors. To this end, we utilized "ChemAI", a deep neural network trained on more than 220M data points across 3.6M molecules from three public drug-discovery databases. With ChemAI, we screened and ranked one billion molecules from the ZINC database for favourable effects against CoV-2. We then reduced the result to the 30,000 top-ranked compounds, which are readily accessible and purchasable via the ZINC database. Additionally, we screened the DrugBank using ChemAI to allow for drug repurposing, which would be a fast way towards a therapy. We provide these top-ranked compounds of ZINC and DrugBank as a library for further screening with bioassays at https://github.com/ml-jku/sars-cov-inhibitors-chemai.

Jose A. Arjona-Medina, Michael Gillhofer, Michael Widrich et al.

We propose RUDDER, a novel reinforcement learning approach for delayed rewards in finite Markov decision processes (MDPs). In MDPs the Q-values are equal to the expected immediate reward plus the expected future rewards. The latter are related to bias problems in temporal difference (TD) learning and to high variance problems in Monte Carlo (MC) learning. Both problems are even more severe when rewards are delayed. RUDDER aims at making the expected future rewards zero, which simplifies Q-value estimation to computing the mean of the immediate reward. We propose the following two new concepts to push the expected future rewards toward zero. (i) Reward redistribution that leads to return-equivalent decision processes with the same optimal policies and, when optimal, zero expected future rewards. (ii) Return decomposition via contribution analysis which transforms the reinforcement learning task into a regression task at which deep learning excels. On artificial tasks with delayed rewards, RUDDER is significantly faster than MC and exponentially faster than Monte Carlo Tree Search (MCTS), TD(λ), and reward shaping approaches. At Atari games, RUDDER on top of a Proximal Policy Optimization (PPO) baseline improves the scores, which is most prominent at games with delayed rewards. Source code is available at \url{https://github.com/ml-jku/rudder} and demonstration videos at \url{https://goo.gl/EQerZV}.

Robert Frank, Michael Widrich, Rahmad Akbar et al.

Generative machine learning models offer a powerful framework for therapeutic design by efficiently exploring large spaces of biological sequences enriched for desirable properties. Unlike supervised learning methods, which require both positive and negative labeled data, generative models such as LSTMs can be trained solely on positively labeled sequences, for example, high-affinity antibodies. This is particularly advantageous in biological settings where negative data are scarce, unreliable, or biologically ill-defined. However, the lack of attribution methods for generative models has hindered the ability to extract interpretable biological insights from such models. To address this gap, we developed Generative Attribution Metric Analysis (GAMA), an attribution method for autoregressive generative models based on Integrated Gradients. We assessed GAMA using synthetic datasets with known ground truths to characterize its statistical behavior and validate its ability to recover biologically relevant features. We further demonstrated the utility of GAMA by applying it to experimental antibody-antigen binding data. GAMA enables model interpretability and the validation of generative sequence design strategies without the need for negative training data.

Leila Arras, Jose A. Arjona-Medina, Michael Widrich et al.

While neural networks have acted as a strong unifying force in the design of modern AI systems, the neural network architectures themselves remain highly heterogeneous due to the variety of tasks to be solved. In this chapter, we explore how to adapt the Layer-wise Relevance Propagation (LRP) technique used for explaining the predictions of feed-forward networks to the LSTM architecture used for sequential data modeling and forecasting. The special accumulators and gated interactions present in the LSTM require both a new propagation scheme and an extension of the underlying theoretical framework to deliver faithful explanations.